Experientia

, Volume 34, Issue 6, pp 821–822 | Cite as

Neuromuscular junction blocking agents: An initial screening bioassay

  • A. Sajdak
  • N. Shaath
Pro Experimentis
  • 8 Downloads

Summary

A simple, rapid and sensitive in vivo bioassay for the initial screening of neuromuscular junction (NMJ) blocking agents has been accomplished. The i.v. retro-orbital plexus (IVROP) mode of injection was utilized, for the first time, in conjunction with the mouse inclined screen bioassay.

Keywords

Initial Screening Neuromuscular Junction Blocking Agent Junction Blocking Screening Bioassay 

References

  1. 5.
    J.O. Hoppe, J. Pharmac. exp. Ther.100, 333 (1950).Google Scholar
  2. 6.
    R.F. Varney, C.R. Linegar and M.A. Holaday, J. Pharmac. exp. Ther.97 72 (1949).Google Scholar
  3. 7.
    J.O. Hoppe, J. Pharmac. exp. Ther.115, 106 (1955).Google Scholar
  4. 8.
    J.MacLagen, Br. J. Pharmac.18 204 (1962).Google Scholar
  5. 9.
    J. Cheymol, F. Bourillet, in: Neuromuscular Blocking and Stimulating Agents., p 297. Ed. C. Madouca-Thomas, Pergamon Press, New York 1972.Google Scholar
  6. 10.
    T.O. Soine and P.W. Erhardt J. pharmac. Sci.64, 53 (1975).Google Scholar
  7. 11.
    A.A. Genenah, T.O. Soine and N.A. Shaath, J. pharmac. Sci.64, 62 (1975).Google Scholar
  8. 12.
    T.O. Soine, W.S. Hanley, N.A. Shaath and A.A. Genenah, J. pharm. Sci.64, 67 (1975).PubMedGoogle Scholar

Copyright information

© Birkhäuser-Verlag 1978

Authors and Affiliations

  • A. Sajdak
    • 1
  • N. Shaath
    • 1
  1. 1.Division of Natural SciencesState University of New YorkPurchaseUSA

Personalised recommendations